Delivery Order SPE2DE24D0013-SPE2D625F1NAM
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,760 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025, with an ultimate completion date of August 27, 2025. This contract carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, which enable the company to provide molecular diagnostic...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,224.80 by the Medical Supply Chain (Defense) on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The contract award is identified as GXGBSLBXC-10 under contract number 4569159077. Cepheid specializes in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1NAMDelivery Order
Cepheid, a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, received a delivery order award valued at $5,443.58 under contract number XPRSMVP-10 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which was not set-aside for any specific business category, was awarded on August 21, 2025, with an ultimate completion date of August 28, 2025. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing engagement with federal defense and healthcare agencies to provide molecular diagnostic testing solutions. This delivery order is likely issued against one of Cepheid's existing indefinite delivery vehicle contracts with the Veterans Integrated Service Networks or Defense Logistics Agency, through which the company provides GeneXpert diagnostic systems, reagents, and test kits for detecting infectious diseases including COVID-19, influenza, RSV, MRSA, and other clinical conditions. The compact timeline and modest contract value suggest this order represents a specific, near-term procurement need within the broader federal molecular diagnostics supply chain supporting defense and veterans' healthcare missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/21/25 |